Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
APPL-01
- Development stage
- Unknown
- Lead developer
- Jupiter Wellness
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
APPL-01 is a topical formulation of minoxidil developed by Applied Biology, Inc., specifically designed for the treatment of androgenetic alopecia (hair loss). Minoxidil is a prodrug that requires conversion into its active form, minoxidil sulfate, by the enzyme sulfotransferase 1A1 (SULT1A1) located in the hair follicle. Many patients exhibit low SULT1A1 activity, leading to poor clinical response to standard minoxidil treatments. APPL-01 incorporates a proprietary adjuvant intended to upregulate or enhance SULT1A1 enzymatic activity, thereby increasing the local concentration of minoxidil sulfate and improving hair regrowth outcomes in individuals previously identified as non-responders.
- Other names
- topical minoxidil formulationSULT1A1-enhanced minoxidilSULT-1A1-enhanced minoxidilSULT 1A1-enhanced minoxidil
Beyond the preview
Go deeper on APPL-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APPL-01.